241710 — Cosmecca Korea Co Balance Sheet
0.000.00%
- KR₩725bn
- KR₩905bn
- KR₩524bn
- 70
- 36
- 90
- 77
Annual balance sheet for Cosmecca Korea Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 31,786 | 30,097 | 26,368 | 39,441 | 64,440 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 54,204 | 82,038 | 86,075 | 113,811 | 119,377 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 149,800 | 183,262 | 186,758 | 221,214 | 255,493 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 156,231 | 155,025 | 155,006 | 159,098 | 207,197 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 358,963 | 391,569 | 392,756 | 432,626 | 517,950 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 141,437 | 135,407 | 142,989 | 154,577 | 170,560 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 229,205 | 249,320 | 246,102 | 263,092 | 299,539 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 129,759 | 142,250 | 146,654 | 169,533 | 218,411 |
| Total Liabilities & Shareholders' Equity | 358,963 | 391,569 | 392,756 | 432,626 | 517,950 |
| Total Common Shares Outstanding |